Fri, January 5, 2024
Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $124 on, Jan 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-124-on-jan-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $110 to $124 on, Jan 3rd, 2024.

Jayson has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023


These are the ratings of the 3 analyists that currently disagree with Jayson


  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $123 on, Monday, December 11th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $133 on, Thursday, October 19th, 2023

Publication Contributing Sources